TNFRSF10B and familial pancreatic carcinoma: These AmphPVP-BTZ-DR5-B and AmphPVP-BTZ-DR5-B-iRGD biocomposites were expected to demonstrate superior DR5 receptor internalization, efficient triggering of apoptotic cell death, and enhanced cytotoxic effects against pancreatic cancer cell lines.